Achieving Drug Costs that Wont Break the Bank

1 / 20
About This Presentation
Title:

Achieving Drug Costs that Wont Break the Bank

Description:

Achieving Drug Costs that Won't Break the Bank. Tom Reed, Unique Industries, Inc. ... too Draconian? Transparency/Rebates. Where does all the money go? ... – PowerPoint PPT presentation

Number of Views:30
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: Achieving Drug Costs that Wont Break the Bank


1
Achieving Drug Costs that Wont Break the Bank
  • Tom Reed, Unique Industries, Inc.
  • Kevin OHara, Corporate Synergies Group, Inc.

2
Overview
  • Current State Of Prescription Drug Coverage
  • Early Attempts at Moderating Costs
  • Viewing Rx as an Independent Cost Driver
  • Getting Aggressive
  • Where Do We Go From Here?

3
Historical Context
  • Prescription Drugs vs. Other Medical Costs
  • The Doubled-Edged Sword of Rx
  • The Transition from Indemnity Models
  • Ridered Prescription Benefits
  • Co-Pay as a Reimbursement Strategy

4
Recent Comparative Change
Source KFF/CMS
5
Actual Underlying Rx Trend
Source Segal, 2006
6
The Two-Edged Sword of Prescription Drugs
  • Americans are clearly spending more each year on
    prescriptions
  • The underlying cost of prescriptions has only
    recently begun to moderate
  • Taking the necessary pharmaceutical agents today
    will likely postpone or eliminate the need for
    costly medical procedures in the future

7
The Shoebox
  • Major Medical-style programs dominated the
    marketplace for the first 50 years of rx coverage
  • Deductible/Co-insurance mechanisms
  • Built-in claims lag and submission suppression
  • Operational inefficiency

8
Co-Pay to the Rescue
  • With the rise in co-pay-based medical programs,
    the co-pay methodology gained a foothold in
    prescription drugs
  • Easy-to administer and less burdensome on the
    member
  • As with medical, tended to isolate the purchaser
    from the underlying cost
  • Single tier plans predominated

9
Shifting the Playing Field
  • Split Co-Pays The Dynamics Begin to Change
  • Separating and the Medical and Prescription
    Elements
  • Administration of Prescription Benefits
  • Carve-Out Rx and their Funding Models

10
Split Co-Pays
  • As the cost escalated and the availability of
    less costly alternatives emerged, two-tier
    co-pays became the norm
  • Reticence to accept the generic as
    pharmacologically equivalent stymied early
    acceptanceand continues today
  • Member and prescription drug manufacturer
    workarounds arose Claritin/Clarinex

11
Three Tiered Formularies
  • Has become the standard
  • Open Formulary/Mixed Model
  • Demonstrated effect on trend
  • Co-Pay Spread Issues
  • Law of Unintended Consequences
  • See Four Tiered Formulary
  • See OTC

12
Pharmacy Benefit Management
  • The rise of PBMs
  • Isolating the Rx and Medical elements
  • Do what you do best
  • Bulk Purchasing/Discounting
  • Flexibility in Plan Design
  • Network
  • Care/Case Management
  • Carve-Out Rx

13
The Case for Carve-Out
  • The Unique Industries Story

14
Techniques
  • Closed Formulary
  • too Draconian?
  • Transparency/Rebates
  • Where does all the money go?
  • What is the REAL underlying cost of the
    prescription medication?
  • Carve-Out Injectibles
  • Determine the medical coverage elements
  • Where appropriate, shift obligation to the
    medical carrier

15
Techniques
  • Benefit Statements for Rx
  • Much like Total Comp or Hidden Paycheck
    statements at year-end
  • Same Usefulness in Reinforcing Company
    Contributions
  • Baseline Drug Formularies
  • Lipitor/Crestor
  • Setting the Cost by Drug and Shifting Focus

16
Techniques
  • Reverse Co-Pay
  • Formulary establishes amount the COMPANY will pay
    by therapeutic category
  • Highlights underlying drug costs and
    pharmacological equivalents
  • Defining AWP/MAC
  • Wide diversity of baselines

17
Techniques
  • Mandatory Generics
  • Mandatory Mail
  • Setting Co-Pay is Crticial
  • The Magic Machine
  • 50 mg and 100 mg Viagra 93.99 (drugstore.com)
  • 20 mg, 40 mg and 80 mg Lipitor 116
    (Walgreens)
  • REAL Consumer Driven Healthcare Employee-Shared
    Savings

18
Techniques
  • Four Tiered Formularies
  • Pitney-Bowes
  • Five (and more) Tiered Formularies
  • Re-Coupling Rx and Medical Care and Disease
    Management
  • Predictive Disease Management Opportunities
  • Facility of Data Exchange

19
Techniques
  • OTC Drug Coverage
  • Nexium/Prilosec
  • Step Therapy
  • Age/Gender/Dosage Edits
  • Re-Importation
  • FSAs and Prescription Coverage

20
Next?
  • Global fees?
  • Medicare as Single Source Payer?
  • Determining Short-Filling?
  • MERPs/HRAs for Prescription?
Write a Comment
User Comments (0)